David-Alexandre C. Gros - 01 May 2023 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Chief Executive Officer, Director
Signature
/s/ David-Alexandre C. Gros
Issuer symbol
ELDN
Transactions as of
01 May 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 18:49:08 UTC
Previous filing
02 Feb 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Common Stock (right to buy) Award $0 +383,299 $0.000000 383,299 01 May 2023 Common Stock 383,299 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 383,299 shares of Common Stock, which option vests with respect to 95,825 shares on May 1, 2024, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending May 1, 2027.